mmHg. For a given PaO 2, the PjvO~ Sjv02 and Cjv02 were lower at eaCO 2 of 25 mmHg than at a PaC02 of 30 mmHg (P < 0.01). The predicted CjvO 2 based on the increased Pa02 and an unchanged cerebral metabolic rate for oxygen was also calculated and was no different from the measured Cjv02 with hyperoxia. Middle cerebral artery flow velocity did not change with hyperoxia, but decreased with hypocapnia (48 5:7 to 35 -k 4 cm" sec -1, P < 0.01). We conclude that hyperoxia during acute hyperventilation in the anaesthetized patient improves oxygen delivery to the cerebral circulation, as measured by a higher cerebral venous oxygen content and saturation. An increased
Acute hyperventilation decreases cerebral blood flow (CBF). 1,2 It causes electroencephalographic slowing consistent with cerebral ischaemia 3 and an increase in brain tissue and cerebrospinal fluid lactate concentrations, 4 that can be reversed with the administration of hyperbaric oxygen. 3,5 Despite this potentially undesirable effect on CBF, hyperventilation reduces cerebral blood volume and intracranial pressure (ICP), and may improve cerebral perfusion pressure (CPP) in some patients. Consequently, hyperventilation provides improved operating conditions and is frequently used during neurosurgical procedures. Intraoperative surgical requirements (reduction of brain bulk) may necessitate marked hyperventilation at the risk of causing cerebral ischaemia. It would be desirable if hyperventilation could be employed to provide improved operating conditions and/or reduce ICP without the accompanying reduction in oxygen delivery to the brain. Increasing the arterial oxygen tension and content may allow greater oxygen delivery to the brain during this vulnerable period. However, hyperoxygenation has been shown to cause cerebral vasoconstriction which may negate the potential improvement in oxygen delivery. 6 To clarify this interaction, we studied the effect of hyperoxia at two levels of PaCO2 on the cerebral venous oxygen content in 12 patients undergoing anaesthesia for neurosurgery.
Methods
The study was approved by the University of Washington Human Subjects Review Committee. After obtaining written consent, 12 patients, ASA physical status 1 or 2, who were about to undergo craniotomies for various elective neurosurgical procedures (nine cerebral aneurysms and three intracranial tumours) were studied. With all routine monitors in place (ECG, arterial catheter, pulse oximetry), patients received a standardized anaesthetic consisting of /v midazolam 1-2 nag, thiopentone 3-5 mg. kg-', fentanyl bolus 3 I~g' kg-r followed by infusion 3 l~g" kg -j" hr-t and vecuronium 0.1 mg. kg -I. After the trachea was intubated, the lungs were mechanically ventilated to normocapnia with an air/oxygen mixture and anaesthesia was maintained with low dose isoflurane (end-tidal 0.5-1.0%). Using an aseptic technique described previously, 7 we inserted a 16-gauge, 13.3 cm retrograde jugular bulb catheter (Angiocath| Becton and Dickinson) in all patients without complication. The catheter was inserted contralateral to the operative site and the position of the catheter was checked radiographically and was satisfactory in all patients studied (tip of the catheter was at the level of and just medial to the mastoid bone). In five patients, surgical conditions permitted the measurement of cerebral blood flow velocity from the middle cerebral artery (MCA) ipsilateral to the jugular venous bulb catheter throughout the study period. The MCA was insonated with a 2 MHz transcranial Doppler probe (Medasonics, Fremont, CA, USA) through the temporal window, using a technique previously described, s A low profde attachment was used to secure the probe in position so that the angle of insonation remained constant throughout the study. Doppler signals were identified and measured at 45-50 mmHg. The shift in frequency spectra of the Doppler signals converted into mean flow velocity (Vmca) were displayed on a video monitor. Flow velocities were recorded at end-expiration.
Under stable anaesthetic and surgical conditions, and at least 30 min after mannitol administration, the patients' lungs were hyperventilated to a PaCO2 of 25 mmHg (+l). A 15-min period of stabilization was allowed at that PaCOv The FIO 2 was then varied to achieve four levels of PaO2: 100-200, 201-300, 301-400 and >400 mmHg. After a further 15 min stabilization at each PaO 2 level, arterial and jugular venous blood gases were drawn (at a rate of <2 ml. rain -1) and Vmca (in five patients) was recorded at each level of PaOv The PaCO2 was then increased to 30 mmHg (4-1) and the same procedure repeated. The tidal volume and respiratory rate were altered in such a manner so as to maintain airway pressure constant, thus minimizing the effects on venous return and cardiac output. The study sequence was randomized so that half of the patients were studied at a PaCO2 of 30 mmHg first and the other half were studied initially at a PaCO2 of 25 mmHg. The blood samples were analyzed using an automated blood gas analyzer (Nova Biomedical 9, Waltham, MA, USA).
Regression lines were constructed for each patient for the PjvO2, SjvO2 and the corresponding PaO2 for both levels of PaCO2. From these lines we calculated the PjvO2, SjvO2, CjvO2 and the arteriovenous oxygen content difference (AVDO2) at PaO2 of 100, 250, and 400 mmHg, at each level of PaCO2 for each patient. The arterial and venous oxygen contents (CaO2, CjvOz) and AVDO2 were calculated from the arterial PO2 and sat- The data were analyzed using two-way analysis of variance for repeated measures. We considered a P value <0.05 statistically significant. To assess the magnitude of cerebra/vasoconstriction secondary to hyperoxygenation, which would result in a CjvO2 value lower than expected based on the increase in oxygen delivery, we derived the predicted CjvO2 and compared it with the measured CjvO2. To do this, we considered PaO2 of I00 mmHg to be normoxia, and calculated the corresponding AVDO2. Assuming an unchanged cerebral metabolic rate (therefore an unchanged ADVO2 if CBF remains constant), we then calculated the CjvO2 at PaO2 of 250 and 400 mmHg. Thus the predicted CjvO2 at PaO2 of 250 mmHg = CaO2 at PaO2 of 250 mmHg -AVDO2 at PaO2 of 100 mmHg and the predicted CjvO2 at PaO2 of 400 mmHg = CaO2 at PaO2 of 400 mmHg -AVDO2 at PaO2 of 100 mmHg.
The predicted values were then compared with the measured values using paired t test. 
Results
The patient data are shown in Table I . There was no change in the patients' body temperature (36 -t-0.5oC), mean arterial pressure (75 + 5 mmHg) or heart rate (75 -t-10 bpm) throughout the study. The SjvO2 vs PaO2 mean regression coefficients for patients at PaCO2 of 25 and 30 mmHg were 0.035 -1-0.01% mmHg -I, 0.85 < r 2 < 0.996 (P < 0.001), and 0.038 + 0.01% mmHg-', 0.840 < r 2 < 0.998 (P < 0.001), respectively.
Hyperoxia increased jugular venous oxygen tension, saturation and content, at both levels of PaCO2 (P < 0.05) (Figures I and 2) . For a given PaO2, the SjvO2, PjvO2 and CjvO2 were higher at a PaCO2 of 30 mmHg than at a PaCO2 of 25 mmHg (P < 0.01) (Tables II  and III) .
At a PaCO2 of 25 mmHg, four patients at PaO2 of 100 mmHg and two patients at PaO2 of 250 mmHg had SjvO2 < 50%, but no patients at PaO2 of 400 mmHg had SjvO2 < 50%. At a PaCO2 of 30 mmHg, one patient at PaO2 of 100 mmHg had SjvO2 < 50% but no patient at PaO2 of 250 and 400 mmHg had SjvO 2 < 50%.
In the five patients monitored with the transcranial Doppler, Vmca did not change with hyperoxia at either level of PaCOv Cerebral blood flow velocity increased from 35 -t-4.0 cm-see -l at a PaCO2 of 25 mmHg to 48 + 7 cm-sec -l at a PaCO 2 of 30 mmHg (P < 0.01) ( Table II) . The measured CjvO2 at hyperoxic PaO2 (PaO2 250 and 400 mmHg) was not different from the predicted CjvO2 (Table III) .
Discussion
The use of hyperventilation during neurosurgical procedures can result in cerebral venous oxygen desaturation (defined as jugular bulb venous oxygen saturations less All values are mean 4-SE. *The difference between SjvO 2 at a PaCO2 of 25 mmHg and SjvO2 at a PaCO 2 of 30 mmHg is statistically significant at P< 0.01. ~The difference between PjvO2 at PaCO2 of 25 mmHg and PjvO 2 at PaCO2 of 30 mmHg is statistically significant at P < 0.01. 5The difference between CBFV at PaCO 2 of 25 mmHg and CBFV at PaCO2 of 30 mmHg is statistically significant at P < 0.01. w difference between SjvO 2 at PaO 2 of 100, 250 and 400 mmHg is statistically significant at P < 0.05. 82 difference between PjvO 2 at PaO2 of 100, 250 and 400 mmHg is statistically significant at P < 0.05. than 50%) in up to 40% of patients undergoing neurosurgery. 7 Although the clinical importance of this intraoperative desaturation remains unclear, at best it is indicative of increased extraction of oxygen with a decreased margin of safety, and at worst, indicative of limited oxygen supply with impending tissue hypoxia. Moreover, the use of hyperventilation in patients with severe head injury has been shown to cause cerebral oligaemia 9 which may lead to a worse neurological outcome, tom Despite this potential adverse effect, hyperventilation can reduce CBE cerebral blood volume and intracranial pressure (ICP), and may improve cerebral perfusion pressure (CPP) in some patients. In addition, hyperventilation may provide improved operating conditions. Our study was designed to test the hypothesis that hyperoxia, by improving oxygen delivery, would improve the margin of safety during hyperventilation.
Kennealy et aL 12 have shown that, in dogs, hyperoxygenating the blood results in an increase in jugular venous bulb and brain tissue oxygen tension. However, others have shown reductions in CBF with hyperoxia in normocapnic piglets, 13 ponies, 14 infants Is and adults. 16 This cerebral vasoconstriction may negate any potential beneficial effects of hyperoxia during hyperventilation. The effect of arterial hyperoxygenation on cerebral venous 0 2 content in anaesthetized patients during acute hyperventilation has not been fully investigated and is the purpose of this study.
We chose two levels of PaCO2, 25 mmHg and 30 mmHg, to assess whether hyperoxygenation improves SjvO2 during moderate and marked hyperventilation. During hyperventilation to a PaCO2 of 25 mmHg, four patients bad SjvO2 < 50% at PaO2 of 100 mmHg and two patients had SjvO2 < 50 at PaO2 of 250 mmHg. At a PaCO2 of 30 mmHg, only one patient had SjvO2 < 50% and this was at a PaO2 of 100 mmHg. There were no episodes of desaturation during hyperoxia at PaO2 of 400 mmHg at either level of PaCO2. Although not applicable to the patients in this study, episodes of cerebral venous desaturation (SjvO2 < 50%) have been shown to be common in patients with head injury even when receiving intensive care with advanced cardiovascular and intracranial monitoring. The observation that bead-injured patients with cerebral venous desaturation had a higher mortality than those without such episodes highlights the potential benefit of detecting and treating such desaturation. 16 It would appear that the most important factor controlling cerebral blood flow (CBF) is PaCO2, as shown by the higher SjvO2, PjvO2 and CjvO2 at the higher PaCO2 of 30 mmHg (P < 0.01). Nonetheless, in the 12 patients studied, hyperoxygenation was beneficial in reducing the incidence of cerebral venous oxygen desaturation during hyperventilation. Hyperoxygenation improved CjvO2 at both levels of PaCO2 (P < 0.05). As the study was conducted during relatively steady-state anaesthetic and surgical conditions, this increase presumably reflects an increase in O2 delivery.
Does normobaric hyperoxygenation produce cerebral vasoconstriction in hypocapnic patients? To answer this question, we derived the predicted CjvO2 based on an unchanged CBF and an unchanged cerebral metabolic rate for oxygen (CMRO2) and compared this to the actual measured CjvO2. We considered PaO2 of 100 mmHg to be normoxia, and calculated the corresponding AVDO2. Assuming an unchanged CMRO2 (therefore an unchanged AVDO2 if CBF stays constant), we then calculated CjvO2 at PaO2 of 250 and 400 mmHg. We found the measured and the predicted CjvO2 to be almost identical with hyperoxia during hypocapnia. This suggests that, during steady state anaesthesia, when CMRO2 is presumed constant, there is no change in CBF when PaCO2 is constant and PaO2 is increased (Table III) . Had there been any decrease in CBF with hyperoxia, the measured CjvO2 would have been lower than the predicted value. The Vmca determination in the five patients with transcranial Doppler monitoring supports this contention and is in agreement with recently published data on Vmca and hyperoxia. 17,~s These findings indicate that the vasoconstrictive response to hyperoxia reported in other studies is abolished by hyperventilation, the anaesthetic conditions employed in this study, or both. It is likely that hypocapnia, even at PaCO2 of 30 mmHg, results in cerebral vasoconstriction that exceeds any vasoconstricfive effect of normobaric hyperoxia.
We conclude that hyperoxia during acute hyperventilation in the anaesthetized patient improves oxygen delivery to the brain as measured by increased cerebral venous oxygen content and saturation. This increase is seen without any apparent change in CBE Hyperoxia should be considered for those patients in whom hyperventilation is contemplated and cerebral ischaemia is considered a risk.
